Clinical Relevance of Matrix Metalloproteinase-13 Determined with a New Highly Specific and Sensitive ELISA in Ascitic Fluid of Advanced Ovarian Carcinoma Patients
-
B. Hantke
, N. Harbeck , B. Schmalfeldt , I. Claes , O. Hiller , M.-O. Luther , A. Welk , W. Kuhn , M. Schmitt , H. Tschesche and B. Muehlenweg
Abstract
Matrix metalloproteinases (MMPs) are involved in many physiological and pathophysiological processes, including tumor cell invasion and metastasis. For one member of this family, MMP-13 (collagenase-3), a new, highly specific ELISA with a sensitivity of 0.5 ng MMP-13/ml was established. The protein levels of MMP-13 in ascitic fluids of 30 patients with advanced ovarian cancer FIGO stage III (n=19) and IV (n=11) were measured with this ELISA. Using a cutoff value of 0.5 ng MMP-13/mg total protein, two patient subpopulations with short (median 16 months) and long (median 36 months) overall survival were identified. Together with other prognostic markers, determination of MMP-13 in ascitic fluid may help to identify patients at risk for early death and help to individualize adjuvant therapy.
Copyright © 2003 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins
- Differential Haemoglobin Gene Expression in the Crustacean Daphnia magna Exposed to Different Oxygen Partial Pressures
- Cloning and Characterization of the Promoter Region of the Mouse Frizzled-Related Protein 4 Gene
- The Bloom's Syndrome Helicase Interacts Directly with the Human DNA Mismatch Repair Protein hMSH6
- Assignment of Disulphide Bridges in Par j 2.0101, a Major Allergen of Parietaria judaica Pollen
- Determination of the NMR Structure of Gln25-Ribonuclease T1
- The Molecular Chaperone, α-Crystallin, Protects against Loss of Antigenicity and Activity of Esterase Caused by Sugars, Sugar Phosphate and a Steroid
- The Activator-Binding Site of Onchocerca volvulus S-Adenosylmethionine Decarboxylase, a Potential Drug Target
- Trans-Sialidase-Like Sequences from Trypanosoma congolense Conserve Most of the Critical Active Site Residues Found in Other Trans-Sialidases
- EGFR and FGFR Signaling through FRS2 Is Subject to Negative Feedback Control by ERK1/2
- The N’-Terminal Domain of Glyceraldehyde-3-Phosphate Dehydrogenase of the Apicomplexan Plasmodium falciparum Mediates GTPase Rab2-Dependent Recruitment to Membranes
- Novel Cell-Permeable Acyloxymethylketone Inhibitors of Asparaginyl Endopeptidase
- Clinical Relevance of Matrix Metalloproteinase-13 Determined with a New Highly Specific and Sensitive ELISA in Ascitic Fluid of Advanced Ovarian Carcinoma Patients
Articles in the same Issue
- Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins
- Differential Haemoglobin Gene Expression in the Crustacean Daphnia magna Exposed to Different Oxygen Partial Pressures
- Cloning and Characterization of the Promoter Region of the Mouse Frizzled-Related Protein 4 Gene
- The Bloom's Syndrome Helicase Interacts Directly with the Human DNA Mismatch Repair Protein hMSH6
- Assignment of Disulphide Bridges in Par j 2.0101, a Major Allergen of Parietaria judaica Pollen
- Determination of the NMR Structure of Gln25-Ribonuclease T1
- The Molecular Chaperone, α-Crystallin, Protects against Loss of Antigenicity and Activity of Esterase Caused by Sugars, Sugar Phosphate and a Steroid
- The Activator-Binding Site of Onchocerca volvulus S-Adenosylmethionine Decarboxylase, a Potential Drug Target
- Trans-Sialidase-Like Sequences from Trypanosoma congolense Conserve Most of the Critical Active Site Residues Found in Other Trans-Sialidases
- EGFR and FGFR Signaling through FRS2 Is Subject to Negative Feedback Control by ERK1/2
- The N’-Terminal Domain of Glyceraldehyde-3-Phosphate Dehydrogenase of the Apicomplexan Plasmodium falciparum Mediates GTPase Rab2-Dependent Recruitment to Membranes
- Novel Cell-Permeable Acyloxymethylketone Inhibitors of Asparaginyl Endopeptidase
- Clinical Relevance of Matrix Metalloproteinase-13 Determined with a New Highly Specific and Sensitive ELISA in Ascitic Fluid of Advanced Ovarian Carcinoma Patients